ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,933Medicare Part D Prescriptions Filled, Including Refills

Rank: 137 out of 783

$572K Total Retail Price of All Prescriptions

Rank: 212 out of 783

385 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 385 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 385 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,719 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 692 617 1 1
SIMVASTATIN 398 338 2 3
FUROSEMIDE 361 306 3 7
OMEPRAZOLE 347 266 4 6
LISINOPRIL 315 241 5 4
METFORMIN HCL 312 203 6 8
METOPROLOL TARTRATE 283 214 7 9
HYDROCODONE-ACETAMINOPHEN 276 239 S3 8 2
METOPROLOL SUCCINATE 252 220 9 13
POTASSIUM CHLORIDE 227 165 10 16
AMLODIPINE BESYLATE 221 198 11 5
GABAPENTIN 218 159 12 15
DONEPEZIL HCL 180 180 13 24
PRAVASTATIN SODIUM 177 155 14 14
HYDROCHLOROTHIAZIDE 136 115 15 12
ALLOPURINOL 135 115 16 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 98 17 33
RANITIDINE HCL 129 114 18 44
TAMSULOSIN HCL 128 115 19 26
MELOXICAM 122 103 20 37
WARFARIN SODIUM 115 99 21 10
FAMOTIDINE 114 85 22 55
SERTRALINE HCL 113 99 23 22
CITALOPRAM HBR 111 63 24 19
LOVASTATIN 104 64 25 58
ENALAPRIL MALEATE 98 92 26 68
CARVEDILOL 96 80 27 21
SPIRONOLACTONE 95 78 28 57
OXYCODONE-ACETAMINOPHEN 94 68 S2 29 76
ISOSORBIDE MONONITRATE ER 92 92 30 40
DILTIAZEM 24HR ER 91 91 31 122
CRESTOR 91 66 31 27
GLIMEPIRIDE 90 66 33 34
CEPHALEXIN 90 63 33 70
KLOR-CON M20 86 80 35 48
TRICOR 85 45 36 134
ROPINIROLE HCL 84 66 37 74
NIASPAN 83 44 38 140
DIGOXIN 82 82 39 61
CLONIDINE HCL 82 68 39 60
SPIRIVA 81 77 41 59
CLOPIDOGREL 80 66 42 29
ALENDRONATE SODIUM 79 79 43 25
ATORVASTATIN CALCIUM 75 25 44 11
LANTUS 75 56 44 38
COMBIVENT 73 48 46 120
VERAPAMIL ER 72 63 47 119
NAMENDA 71 71 48 32
PLAVIX 71 57 48 51
LOSARTAN POTASSIUM 70 49 50 18
NEXIUM 70 62 50 28
PROAIR HFA 69 63 52 56
TRIAMTERENE-HCTZ 68 31 53 42
AZITHROMYCIN 66 52 54 41
LEVOFLOXACIN 64 56 55 75
TRANSDERM-SCOP 59 59 56 275
TRAMADOL HCL 59 42 56 20
GEMFIBROZIL 56 40 58 105
PANTOPRAZOLE SODIUM 55 45 59 30
RISPERIDONE 54 54 60 67
FENTANYL 51 51 S2 61 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.